12 reports

OPTIMISTIC SCENARIO: This represents our optimistic view of the growth in the market, wherein we have been positive with the adoption rates and level of outsourcing activity.

  • Digestive System Disorder
  • United States
  • Enterome Bioscience SA
  • MicroBiome Therapeutics LLC
  • Seres Therapeutics, Inc.
  • Cholesterol
  • Digestive System Disorder
  • Obesity
  • Pharmaceutical
  • Esperion Therapeutics, Inc.

Completed ##-Aug-2011 NovAliX SAS NovAliX SAS (NovAliX) is a contract research organization that provides outsourcing and insourcing research services for drug discovery.

  • Digestive System Disorder
  • Pharmaceutical
  • Risky Behaviour
  • United States
  • Galapagos NV

FMR also offers retirement planning, benefits outsourcing services, wealth management, estate planning and inheritance and tax services.

  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • AbbVie Inc.

outsourcing of distribution.

  • Digestive System Disorder
  • Pharmaceutical
  • United States
  • M&A
  • Allergan plc

THE FIRM' S BUSINESS SECTOR INCLUDES TRANSPORT, LOGISTICS AND DISTRIBUTION, FACILITIES AND INFRASTRUCTURE MANAGEMENT, BUSINESS PROCESS OUTSOURCING, IT SERVICES, RENTAL SERVICES, INSPECTION AND TESTING, EDUCATION AND STAFFING.

  • Digestive System Disorder
  • Pharmaceutical
  • United States
  • Company Financials
  • Novartis AG
  • DEBIO-0930B - DRUG PROFILE
  • Digestive System Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Following the clearance, the Company engaged Quintiles, the world' s largest provider of biopharmaceutical development and commercial outsourcing services, to conduct its PK study.

  • Digestive System Disorder
  • Endocrine Disease
  • United States
  • Company
  • Product Initiative

Hospitals are increasingly outsourcing diagnostics tests to diagnostics laboratories to reduce incurred costs and technical issues involved in managing laboratories.

  • Digestive System Disorder
  • Asia
  • Europe
  • World
  • Market Size

KRS GLOBAL IS A ##B FDA APPROVED OUTSOURCING FACILITY CAPABLE OF COMPOUNDING NALTREXONE TABLETS IN VARIOUS STRENGTHS FOR INDIVIDUAL PATIENTS IN RESPONSE TO A PRESCRIPTION FROM A LICENSED PHYSICIAN.

  • Digestive System Disorder
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

KRS GLOBAL IS A ##B FDA APPROVED OUTSOURCING FACILITY CAPABLE OF COMPOUNDING NALTREXONE TABLETS IN VARIOUS STRENGTHS FOR INDIVIDUAL PATIENTS IN RESPONSE TO A PRESCRIPTION FROM A LICENSED PHYSICIAN.

  • Arthritis
  • Digestive System Disorder
  • Monoclonal Antibody
  • United States
  • Product Initiative

Furthermore, there will be significant cost efficiencies rather than outsourcing the manufacturing process to a third-party.

  • Digestive System Disorder
  • Hospital
  • Pharmaceutical
  • Therapy
  • Merck & Co., Inc.